好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Migrainous features of multiple sclerosis (MS) users of MS Care ConnectTM, a self-efficacy mHealth digital application
Multiple Sclerosis
P1 - Poster Session 1 (9:00 AM-5:00 PM)
348

We used a retrospective, cross-sectional dataset from MSCCTM, a digital application (InterPRO Bioscience) of Multiple Sclerosis (MS) patients, to assess the relationship of migraine with MS disability or severity.

Migraine presents simultaneously with early MS in most patients and is associated with MS prevalence and incidence. However, the pathological significance of migraine to MS disability or severity remains unclear.

We used patient survey responses to identify likely migraineurs (chronic vs. episodic). We tested an association between migraineur status and MS disability or severity after controlling for demographic variables with mixed-effects models. We tested two measures of MS disability, Patient-Derived Disability Score (PDDS) and MS-related Work Disruption (MS-RWD), and one measure of MS severity, Patient-Derived MS Severity Score (P-MSSS).

87% of mHealth headache survey respondents (N=253) self-reported headache. Mean patient age was 45.4 y (±11.4SD), with 79% female. Respondent self-reported their diagnosis as follows: 78% RRMS/CIS, 10% PP/SPMS, and 11% unsure. Mean participant PDDS was 2.15 (±1.9SD), mean P-MSSS decile was 4.3 (±2.6SD), and 41.9% reported MS-related limitations/disability at work (MS-RWD). Only 6.3% of patients reported relapse within six weeks of the survey.

Half of migraineurs met criteria for episodic vs. chronic migraine diagnosis.  Mixed models showed neither PDDS nor P-MSSS is associated with higher odds of being migraineur; however, the odds of a patient with MS-related disability being migraineur is twice that of a patient with no limitations/disability. Younger, heavier, or female patients also have higher odds of being migrainous. Notably, one-third of migraineurs identified here reported treatment for headaches.

Using an mHealth dataset, we find disabled, younger, heavier, or female patients have increased odds of episodic and chronic migraines. This study reveals the small fraction of MS patients receiving headache treatment. Further, it demonstrates the usefulness of an mHealth application for migraine screening of MS patients.

Authors/Disclosures
Amy L. Dix, PA (Association of Neurology PAs)
PRESENTER
Ms. Dix has nothing to disclose.
John F. Foley, MD, FAAN (Rocky Mountain MS Clinic) The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
No disclosure on file